Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy
encephalitis · 2022
DOI: 10.47936/encephalitis.2021.00143 ↗Kurz gefasst
Fallbericht in der Zeitschrift encephalitis, 2022. Verfasst von Juhee Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Monoclonal gammopathy of undetermined significance (MGUS) is associated with several autoimmune conditions, including central nervous system (CNS) vasculitis. Epstein-Barr virus (EBV) is a pathogen capable of triggering a systemic immune response and is involved in the occurrence of a wide range of B-cell lymphoproliferative disorders. In systemic autoimmune diseases, EBV infection is suspected to play a central role in pathogenesis. Here, we present a case that was thought to be a systemic autoimmune disease and CNS vasculitis that developed after EBV infection, demonstrating that rituximab is effective for the treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Center for Hospital Medicine, Seoul National University Hospital, Seoul, Korea.
- Comprehensive Epilepsy Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Kon Chu
Zitieren
APA
Lee, J., Lee, H. S., & Chu, K. (2022). Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy. encephalitis. https://doi.org/10.47936/encephalitis.2021.00143
Vancouver
Lee J, Lee HS, Chu K. Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy. encephalitis. 2022. doi:10.47936/encephalitis.2021.00143
BibTeX
@article{Lee2022,
author = {Lee, Juhee and Lee, Han Sang and Chu, Kon},
title = {Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy},
journal = {encephalitis},
year = {2022},
doi = {10.47936/encephalitis.2021.00143}
}
EUVIMED